SEC Form 4 research
| Issuer | RxSight, Inc. |
|---|---|
| Tickers | RXST |
| Reporting owners | 25 |
| Officers and directors | 11 |
| Last public filing | 2026-09-10 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-09 | 2026-09-05 | Wilterding Mark | A | 258,770 | Not reported | Not reported |
| 2026-09-09 | 2026-09-05 | Weinberg Eric | A | 32,258 | Not reported | Not reported |
| 2026-09-09 | 2026-09-05 | Weinberg Eric | A | 59,483 | Not reported | Not reported |
| 2026-09-09 | 2026-09-05 | Weinberg Eric | A | 82,608 | Not reported | Not reported |
| 2026-09-09 | 2026-09-05 | Weinberg Eric | A | 65,742 | Not reported | Not reported |
| 2026-09-09 | 2026-09-05 | Weinberg Eric | A | 93,984 | Not reported | Not reported |
| 2026-09-09 | 2026-09-05 | Kurtz Ronald M MD | A | 161,654 | Not reported | Not reported |
| 2026-09-09 | 2026-09-05 | Kurtz Ronald M MD | A | 96,129 | Not reported | Not reported |
| 2026-09-09 | 2026-09-05 | Kurtz Ronald M MD | A | 173,913 | Not reported | Not reported |
| 2026-09-09 | 2026-09-05 | Kurtz Ronald M MD | A | 254,751 | Not reported | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.